110 related articles for article (PubMed ID: 12590571)
1. A novel modeling protocol for protein receptors guided by bound-ligand conformation.
Johnson MA; Höög C; Pinto BM
Biochemistry; 2003 Feb; 42(7):1842-53. PubMed ID: 12590571
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
Covaceuszach S; Cattaneo A; Lamba D
Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
[TBL] [Abstract][Full Text] [Related]
3. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
Paula S; Monson N; Ball WJ
Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
[TBL] [Abstract][Full Text] [Related]
4. Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactions.
Strömbergsson H; Prusis P; Midelfart H; Lapinsh M; Wikberg JE; Komorowski J
Proteins; 2006 Apr; 63(1):24-34. PubMed ID: 16435365
[TBL] [Abstract][Full Text] [Related]
5. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
Moretti L; Pentikäinen OT; Settimo L; Johnson MS
J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
[TBL] [Abstract][Full Text] [Related]
6. Structural consensus in ligand-protein docking identifies recognition peptide motifs that bind streptavidin.
Shah NK; Rejto PA; Verkhivker GM
Proteins; 1997 Jul; 28(3):421-33. PubMed ID: 9223187
[TBL] [Abstract][Full Text] [Related]
7. GEMDOCK: a generic evolutionary method for molecular docking.
Yang JM; Chen CC
Proteins; 2004 May; 55(2):288-304. PubMed ID: 15048822
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional structures of a humanized anti-IFN-gamma Fab (HuZAF) in two crystal forms.
Bourne PC; Terzyan SS; Cloud G; Landolfi NF; Vásquez M; Edmundson AB
Acta Crystallogr D Biol Crystallogr; 2004 Oct; 60(Pt 10):1761-9. PubMed ID: 15388922
[TBL] [Abstract][Full Text] [Related]
9. Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation.
Talavera A; Friemann R; Gómez-Puerta S; Martinez-Fleites C; Garrido G; Rabasa A; López-Requena A; Pupo A; Johansen RF; Sánchez O; Krengel U; Moreno E
Cancer Res; 2009 Jul; 69(14):5851-9. PubMed ID: 19584289
[TBL] [Abstract][Full Text] [Related]
10. Anchoring a cationic ligand: the structure of the Fab fragment of the anti-morphine antibody 9B1 and its complex with morphine.
Pozharski E; Wilson MA; Hewagama A; Shanafelt AB; Petsko G; Ringe D
J Mol Biol; 2004 Mar; 337(3):691-7. PubMed ID: 15019787
[TBL] [Abstract][Full Text] [Related]
11. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
12. ABGEN: a knowledge-based automated approach for antibody structure modeling.
Mandal C; Kingery BD; Anchin JM; Subramaniam S; Linthicum DS
Nat Biotechnol; 1996 Mar; 14(3):323-8. PubMed ID: 9630894
[TBL] [Abstract][Full Text] [Related]
13. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the stereoselectivity of an anti-amino acid antibody using molecular modeling and ligand docking.
Ranieri DI; Corgliano DM; Franco EJ; Hofstetter H; Hofstetter O
Chirality; 2008 Mar; 20(3-4):559-70. PubMed ID: 18172831
[TBL] [Abstract][Full Text] [Related]
15. Generalized modeling of enzyme-ligand interactions using proteochemometrics and local protein substructures.
Strömbergsson H; Kryshtafovych A; Prusis P; Fidelis K; Wikberg JE; Komorowski J; Hvidsten TR
Proteins; 2006 Nov; 65(3):568-79. PubMed ID: 16948162
[TBL] [Abstract][Full Text] [Related]
16. Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antibody agonists.
Li B; Russell SJ; Compaan DM; Totpal K; Marsters SA; Ashkenazi A; Cochran AG; Hymowitz SG; Sidhu SS
J Mol Biol; 2006 Aug; 361(3):522-36. PubMed ID: 16859704
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the binding of a carbohydrate-mimetic peptide to its complementary anticarbohydrate antibody by STD-NMR spectroscopy and molecular-dynamics simulations.
Szczepina MG; Bleile DW; Pinto BM
Chemistry; 2011 Oct; 17(41):11446-55. PubMed ID: 21953925
[TBL] [Abstract][Full Text] [Related]
18. Characterizing monoclonal antibody epitopes by filtered gene fragment phage display.
Di Niro R; Ferrara F; Not T; Bradbury AR; Chirdo F; Marzari R; Sblattero D
Biochem J; 2005 Jun; 388(Pt 3):889-94. PubMed ID: 15720292
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure analysis and in silico pKa calculations suggest strong pKa shifts of ligands as driving force for high-affinity binding to TGT.
Ritschel T; Hoertner S; Heine A; Diederich F; Klebe G
Chembiochem; 2009 Mar; 10(4):716-27. PubMed ID: 19199329
[TBL] [Abstract][Full Text] [Related]
20. Docking of combinatorial peptide libraries into a broadly cross-reactive human IgM.
Yuriev E; Ramsland PA; Edmundson AB
J Mol Recognit; 2001; 14(3):172-84. PubMed ID: 11391788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
